What is the current Global Non-Small Cell Lung Cancer (NSCLC) Market size?

The Global Non-Small Cell Lung Cancer (NSCLC) Market is projected to register a CAGR of 9.5% during the forecast period (2024-2029) Read More

Who are the key players in Global Non-Small Cell Lung Cancer (NSCLC) Market?

F. Hoffmann-La Roche Ltd. , Bristol-Myers Squibb Company, Pfizer Inc. , AstraZeneca and Novartis AG are the major companies operating in the Global Non-Small Cell Lung Cancer (NSCLC) Market. Read More

Which is the fastest growing region in Global Non-Small Cell Lung Cancer (NSCLC) Market?

Asia-Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029). Read More

Which region has the biggest share in Global Non-Small Cell Lung Cancer (NSCLC) Market?

In 2024, the North America accounts for the largest market share in Global Non-Small Cell Lung Cancer (NSCLC) Market. Read More

What years does this Global Non-Small Cell Lung Cancer (NSCLC) Market cover?

The report covers the Global Non-Small Cell Lung Cancer (NSCLC) Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Global Non-Small Cell Lung Cancer (NSCLC) Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029. Read More

Non-Small Cell Lung Cancer (NSCLC) Market Share

Statistics for the 2023 & 2024 Non-Small Cell Lung Cancer (NSCLC) market share, created by Mordor Intelligence™ Industry Reports. Non-Small Cell Lung Cancer (NSCLC) share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Market Share of Non-Small Cell Lung Cancer (NSCLC) Industry

The non-small cell lung cancer market is fragmented and competitive and consists of several major players. The companies are adopting various key business strategies such as collaborations, partnerships, new product launches and other initiatives to withhold their market position. Some of the key companies in the market are F. Hoffmann-La Roche, AstraZeneca, Bristol-Myers Squibb, Merck, Novartis, Pfizer, Takeda Pharmaceuticals, Bayer Healthcare, Eli Lilly and Company, and GlaxoSmithKline among others.